Diabetes basic science research takes centre stage.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Works matching IS 07423071 AND DT 2021 AND VI 38 AND IP 12
Results: 18
1
2
Neonatal diabetes caused by disrupted pancreatic and β‐cell development.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14728
- Publication type:
- Article
3
Dorothy Hodgkin Lecture 2021: Drugs, genes and diabetes.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14726
- Publication type:
- Article
4
Expression of CD47 in the pancreatic β‐cells of people with recent‐onset type 1 diabetes varies according to disease endotype.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14724
- By:
- Publication type:
- Article
5
Hypoglycaemia: Still the main drawback of insulin 100 years on: "From man to mouse".
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14721
- By:
- Publication type:
- Article
6
Replacing insulin with immunotherapy: Time for a paradigm change in Type 1 diabetes.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14696
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14485
- Publication type:
- Article
8
100 years of insulin—enormous gratitude for my extra 65 years!
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14682
- Publication type:
- Article
9
Persistence of islet autoantibodies after diagnosis in type 1 diabetes.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14712
- By:
- Publication type:
- Article
10
Amplifying the antidiabetic actions of glucagon‐like peptide‐1: Potential benefits of new adjunct therapies.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14699
- By:
- Publication type:
- Article
11
Four decades of the Bart's Oxford study: Improved tests to predict type 1 diabetes.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14717
- By:
- Publication type:
- Article
12
Automated insulin dosing systems: Advances after a century of insulin.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14695
- By:
- Publication type:
- Article
13
The use of mice in diabetes research: The impact of physiological characteristics, choice of model and husbandry practices.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14711
- By:
- Publication type:
- Article
14
The use of mice in diabetes research: The impact of experimental protocols.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14705
- By:
- Publication type:
- Article
15
Winner's curse: The sad aftermath of the discovery of insulin.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14677
- By:
- Publication type:
- Article
16
100 years of physiology, discrimination and wonder.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14642
- By:
- Publication type:
- Article
17
The contributions of insulin to science in medicine.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14623
- By:
- Publication type:
- Article
18
Developmental programming by maternal obesity: Lessons from animal models.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 12, p. 1, doi. 10.1111/dme.14694
- By:
- Publication type:
- Article